Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Asset Utilization Ratio (2017 - 2023)

Acro Biomedical (ACBM) has 7 years of Asset Utilization Ratio data on record, last reported at 1.29 in Q3 2023.

  • For Q3 2023, Asset Utilization Ratio fell 5.54% year-over-year to 1.29; the TTM value through Sep 2023 reached 1.29, down 5.54%, while the annual FY2022 figure was 0.91, 33.22% down from the prior year.
  • Asset Utilization Ratio reached 1.29 in Q3 2023 per ACBM's latest filing, up from 0.6 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 4.94 in Q1 2019 and bottomed at 1.16 in Q4 2019.
  • Average Asset Utilization Ratio over 5 years is 1.0, with a median of 0.9 recorded in 2021.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 137.8% in 2020, then skyrocketed 1724.91% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 1.16 in 2019, then skyrocketed by 159.63% to 0.69 in 2020, then skyrocketed by 148.68% to 1.72 in 2021, then crashed by 42.54% to 0.99 in 2022, then surged by 30.38% to 1.29 in 2023.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 1.29 in Q3 2023, 0.6 in Q2 2023, and 0.54 in Q1 2023.